A carregar...
Nivolumab-induced immune-mediated neurotoxicity in Hodgkin lymphoma
Nivolumab, a monoclonal antibody against programmed cell death-1 used to treat multiple cancers, has fewer side effects than traditional chemotherapy but has displayed a propensity to cause a host of immune-related adverse events. We describe a case of nivolumab immune-mediated neurotoxicity in a 42...
Na minha lista:
| Publicado no: | Proc (Bayl Univ Med Cent) |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6988700/ https://ncbi.nlm.nih.gov/pubmed/32063772 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/08998280.2019.1668719 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|